Manuel Grossmann

Verified profile

Venture Capital, Private Equity Firm, Angel/Individual · Germany

Manuel Grossmann is a venture capital investor and private equity investor based in Germany. They invest in Life Science, Synthetic Biology, Biotechnology and Electronic Health Records (EHR), typically at the Series A stage. Their portfolio includes Allcyte and KREATIZE.

Investment stages

Industries

Portfolio companies (2)

  • Allcyte
  • KREATIZE

Similar investors in Life Science

  • Stefan Herr

    Venture Capital, Private Equity Firm, Micro VC · Germany

    Health CareChemicalLife ScienceBioinformatics

    Portfolio: Topas Therapeutics, Crescendo Biologics

    Contact details available

  • Niklas Windmann

    Venture Capital, Private Equity Firm · Germany

    Health CareEnergyChemicalLife Science

    Portfolio: GOVECS, Inside Secure

    Contact details available

  • Matthias Kromayer

    Venture Capital, Entrepreneurship Program, Private Equity Firm · Germany

    Health CareCommercialWearablesCustomer Service

    Portfolio: Siltectra, Hemovent

    Contact details available

  • Ferdinand Becker

    Venture Capital, Private Equity Firm · Germany

    Health CareEnergyChemicalLife Science

    Portfolio: GOVECS, Inside Secure

    Contact details available

  • Oliver Kahl

    Venture Capital, Entrepreneurship Program, Private Equity Firm · Germany

    Health CareCommercialWearablesCustomer Service

    Portfolio: Siltectra, Hemovent

    Contact details available

  • Holger Reithinger

    Venture Capital, Investor · Germany

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma

    Contact details available

  • Marco Zeller

    Venture Capital, Government Office, Entrepreneurship Program · Germany

    SeedHealth CareAutonomous VehiclesCybersecurityDatabases

    Portfolio: Aignostics, Meetrics

    Contact details available

  • Christian ArndtVerified

    Venture Capital, Private Equity Firm, Investor · Germany

    SeedAutonomous VehiclesCybersecurityEnterprise SoftwareCryptocurrency

    Contact details available